May 15, 2023 / 06:00PM GMT
Silvan Türkcan - JMP Securities LLC - Analyst
Okay, welcome back. My name is Silvan Türkcan. I cover precision medicines here at JMP Securities. It's my pleasure to host Erin Quirk --
Mark Vignola - Terns Pharmaceuticals, Inc. - CFO
Kerry Russell.
Silvan Türkcan - JMP Securities LLC - Analyst
Sorry, Kerry Russell and Mark Vignola from Terns Pharmaceuticals. Thank you so much for joining us today.
Mark Vignola - Terns Pharmaceuticals, Inc. - CFO
Thanks so much for having us. It's great to be here.
Kerry Russell - Terns Pharmaceuticals, Inc. - Chief Medical Officer, Metabolic
Thank you, Silvan.
Questions and Answers:
Silvan Türkcan - JMP Securities LLC - AnalystTerns is focused on developing, obviously, small molecules for -- with different mechanisms of action about a host of indications, and -- but some investors may still know you as the NASH company or a NASH company. So